These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1605292)

  • 1. Use of two types of estradiol-releasing skin patches for menopausal patients in a tropical climate.
    McCarthy T; Dramusic V; Ratnam S
    Am J Obstet Gynecol; 1992 Jun; 166(6 Pt 2):2005-10. PubMed ID: 1605292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse skin reactions to transdermal oestradiol in tropical climate. A comparative study of skin tolerance after using oestradiol patch and gel in Thai postmenopausal women.
    Sentrakul P; Chompootaweep S; Sintupak S; Tasanapradit P; Tunsaringkarn K; Dusitsin N
    Maturitas; 1991 Jun; 13(2):151-4. PubMed ID: 1833610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of gel and patch estradiol replacement in Brazil, a tropical country.
    Travassos de Figueiredo Alves ; Amélia Sobreira Gomes M; Clapauch R
    Maturitas; 2000 Jul; 36(1):69-74. PubMed ID: 10989244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin reactions with transdermal estradiol therapy in a tropical environment.
    Bhathena RK; Anklesaria BS; Ganatra AM
    Int J Gynaecol Obstet; 1998 Feb; 60(2):177-9. PubMed ID: 9509960
    [No Abstract]   [Full Text] [Related]  

  • 5. An Australian experience of transdermal oestradiol patches in a subtropical climate.
    O'Neill S; Kirkegard Y
    Aust N Z J Obstet Gynaecol; 1993 Aug; 33(3):327-9. PubMed ID: 8304906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin reactions to transdermal estrogen replacement therapy in a tropical climate.
    de Cetina TC; Reyes LP
    Int J Gynaecol Obstet; 1999 Jan; 64(1):71-2. PubMed ID: 10190675
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy on climacteric symptoms of a new estradiol transdermal patch with active matrix in comparison with a reference reservoir patch. Two long-term randomized multicenter parallel-group studies.
    Rovati LC; Schmid K; Giacovelli G; Bonn M; Setnikar I; Wolff F; Genazzani AR
    Arzneimittelforschung; 1999 Nov; 49(11):933-43. PubMed ID: 10604047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [17 beta-estradiol. as a patch. An elixir of youth as a prescription for the menopausal woman].
    Taeron C
    Rev Infirm; 2002 Mar; (79):45-7. PubMed ID: 11979678
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative study to evaluate skin irritation and adhesion of Estradot and Climara in healthy postmenopausal women.
    Ibarra de Palacios P; Schmidt G; Sergejew T; Quebe-Fehling E; Lockhart L; Krinsky L
    Climacteric; 2002 Dec; 5(4):383-9. PubMed ID: 12626218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New trends in transdermal technologies: development of the skin patch, Menorest.
    Marty JP
    Int J Gynaecol Obstet; 1996 Mar; 52 Suppl 1():S17-20. PubMed ID: 8666122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical experience with a seven-day estradiol transdermal system for estrogen replacement therapy.
    Gordon SF
    Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 2):998-1004. PubMed ID: 7573298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of microbial proliferation and phototoxic potential of a new matrix patch for estradiol delivery.
    Mulberry GK; Della-Cioppa G; Monza G; Harper RA; Oelrich DM
    Maturitas; 1996 Nov; 25(3):223-9. PubMed ID: 8981340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience with Systen, a new transdermal form of hormone replacement therapy.
    Corson SL
    Int J Fertil Menopausal Stud; 1993; 38 Suppl 1():36-44. PubMed ID: 8499958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estradiol gel: review of the pharmacology, pharmacokinetics, efficacy, and safety in menopausal women.
    Naunton M; Al Hadithy AF; Brouwers JR; Archer DF
    Menopause; 2006; 13(3):517-27. PubMed ID: 16735950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of transdermal and oral HRT for menopausal symptom control.
    Akhila V; Pratapkumar
    Int J Fertil Womens Med; 2006; 51(2):64-9. PubMed ID: 16881381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy on climacteric symptoms and safety of low dose estradiol transdermal matrix patches. A randomized, double-blind placebo-controlled study.
    De Aloysio D; Rovati LC; Giacovelli G; Setnikar I; Bottiglioni F
    Arzneimittelforschung; 2000 Mar; 50(3):293-300. PubMed ID: 10758784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of continuous sequential transdermal estradiol and norethindrone acetate in relieving vasomotor symptoms associated with menopause.
    Notelovitz M; Cassel D; Hille D; Furst KW; Dain MP; VandePol C; Skarinsky D
    Am J Obstet Gynecol; 2000 Jan; 182(1 Pt 1):7-12. PubMed ID: 10649149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal delivery of sex steroids for hormone replacement therapy and contraception. A review of principles and practice.
    Henzl MR; Loomba PK
    J Reprod Med; 2003 Jul; 48(7):525-40. PubMed ID: 12953327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrasorb.
    Chiechi LM
    IDrugs; 2004 Sep; 7(9):860-4. PubMed ID: 15470604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticle delivery for transdermal HRT.
    Valenzuela P; Simon JA
    Nanomedicine; 2012 Sep; 8 Suppl 1():S83-9. PubMed ID: 22640909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.